← Back to Search

Survivorship Program for Young Adult Cancer Survivors

N/A
Recruiting
Led By Melody A Griffith
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Treated with curative intent
Age 18-39
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 6 weeks
Awards & highlights

Study Summary

This trial evaluates the effectiveness of a 6-week group curriculum to help AYA cancer survivors learn to cope with survivorship & re-enter daily life.

Who is the study for?
This trial is for young adults aged 18-39 who are cancer survivors, treated at Mayo Clinic Arizona with the intent to cure. They must have completed treatment within the last 6 months to 2 years, be able to attend six group sessions, and participate in a group setting. Excluded are those without internet or computer access, currently receiving cancer treatment, on hospice care, or with severe illnesses that could interfere with the study.Check my eligibility
What is being tested?
The trial tests a 6-week group curriculum aimed at improving life after cancer for adolescent and young adult survivors. Facilitated by licensed social workers, it offers education and support tailored to their unique needs post-treatment. The effectiveness of this program will determine its potential use across Mayo Clinic sites and possibly other centers.See study design
What are the potential side effects?
Since this intervention involves counseling and educational activities rather than medical treatments or drugs, traditional side effects aren't expected. However, participants may experience emotional discomfort discussing their experiences.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My treatment was aimed at curing my condition.
Select...
I am between 18 and 39 years old.
Select...
I have been diagnosed with cancer before.
Select...
I can take part in group activities.
Select...
I finished my cancer treatment between 6 months and 2 years ago.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 6 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 6 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in quality of life
Secondary outcome measures
Change in well-being

Trial Design

1Treatment groups
Experimental Treatment
Group I: Supportive Care (group curriculum)Experimental Treatment6 Interventions
Participants attend an online group facilitated by two oncology social workers and receive information regarding coping with cancer survivorship as a young adult, as well as discuss survivorship issues/concerns with peers.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Discussion
2021
N/A
~130

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH
13,627 Previous Clinical Trials
40,927,375 Total Patients Enrolled
1 Trials studying Blood Cancers
70 Patients Enrolled for Blood Cancers
Mayo ClinicLead Sponsor
3,191 Previous Clinical Trials
3,758,491 Total Patients Enrolled
Melody A GriffithPrincipal InvestigatorMayo Clinic

Media Library

Group Curriculum Clinical Trial Eligibility Overview. Trial Name: NCT05584449 — N/A
Blood Cancers Research Study Groups: Supportive Care (group curriculum)
Blood Cancers Clinical Trial 2023: Group Curriculum Highlights & Side Effects. Trial Name: NCT05584449 — N/A
Group Curriculum 2023 Treatment Timeline for Medical Study. Trial Name: NCT05584449 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What type of individuals would be most suitable for this trial?

"Applicants to this trial need to be between 18 and 39 years old, have a neoplastic disease, and should note that only 20 patients will be accepted."

Answered by AI

Is the eligibility for this clinical trial limited to adults over twenty years of age?

"This clinical trial seeks to include participants aged 18 or over, up until 39 years old."

Answered by AI

Are any fresh volunteers being accepted for this experiment?

"According to the records found on clinicaltrials.gov, this experiment is currently not recruiting participants; however, it was initially posted on December 15th 2022 and received its last update as of November 29th 2022. Despite this trial being closed off at present, there are still 2403 other investigations that require volunteers presently."

Answered by AI
~6 spots leftby Oct 2024